Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Dechra Pharmaceuticals PLC

DPHAY•PNK
Healthcare
Drug Manufacturers - General
$98.00
$1.90(1.98%)
U.S. Market opens in 5h 7m

Dechra Pharmaceuticals PLC (DPHAY) Stock Overview

Explore Dechra Pharmaceuticals PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.6B
P/E Ratio-295.47
EPS (TTM)$-0.63
ROE-0.04%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$155.63

DPHAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dechra Pharmaceuticals PLC (DPHAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $155.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -295.47 and a market capitalization of 5.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
1.98%
3-Month Change
3.95%
6-Month Change
3.95%
Year-to-Date (YTD) Change
3.95%
1-Year Change
31.92%
3-Year Change
41.007%
5-Year Change
44.12%
All-Time (Max) Change
44.12%

Contact Information

https://www.dechra.com
44 1606 814730
24 Cheshire Avenue, Northwich, NaN, CW9 7UA

Company Facts

24,570 Employees
IPO DateFeb 26, 2018
CountryGB

Frequently Asked Questions